Anavar

Anavar was developed by Searle Laboratories in the 1960s and introduced under the brand name Anavar, later generically available as Oxandrolone. It was developed with the explicit goal of creating a safer anabolic steroid with a high anabolic-to-androgenic ratio — meaning strong muscle and strength effects relative to masculinizing side effects. As a DHT derivative, Anavar does not convert to estrogen via aromatase — eliminating the gynecomastia and water retention risks associated with testosterone and many other anabolic steroids. This estrogenic neutrality makes it one of the cleanest aesthetics for lean mass preservation and strength without the bloat associated with wet compounds. Anavar retains FDA approval for specific medical indications including muscle wasting from surgery, chronic infection, trauma, and osteoporosis. This medical history has generated more legitimate clinical data than most other anabolic steroids, giving it a more established human safety profile within therapeutic dose ranges.

Lean strength gains without water retention are Anavar's signature benefit. Users consistently report significant strength increases — often disproportionate to actual muscle mass gained — attributed to phosphocreatine synthesis enhancement and direct androgen receptor effects on the neuromuscular system. These strength gains occur without the significant water and glycogen retention that makes testosterone-based strength gains partly artificial. Muscle preservation during caloric deficit is where Anavar excels clinically and practically. Multiple studies have confirmed its ability to prevent muscle catabolism during periods of reduced calorie intake, making it valuable in cutting phases where the goal is fat loss without sacrificing lean mass. Female safety at low doses is one of Anavar's distinguishing characteristics. While no anabolic steroid is completely safe for women, Anavar's reduced androgenic activity means virilization side effects (voice deepening, clitoral enlargement, facial hair) occur at lower doses and progress more slowly than with most other anabolics, giving women more time to identify and respond to early signs.

Liver hepatotoxicity is the primary safety concern. As a 17-alpha alkylated oral steroid, Anavar passes through the liver in a form that resists first-pass metabolism but simultaneously stresses hepatic tissue. Liver enzyme elevation is expected; actual hepatic damage requires significantly higher doses or extended use. Liver support supplements (TUDCA, NAC) and cycle length limitations (maximum 6–8 weeks) are standard practice. HDL cholesterol suppression is the most clinically significant cardiovascular risk. Anavar reliably and substantially reduces HDL ("good") cholesterol while modestly raising LDL. This lipid profile deterioration increases cardiovascular risk during use and should be monitored with bloodwork. Testosterone suppression — while generally milder than testosterone-based compounds — is still meaningful at typical performance doses. Men using Anavar without a testosterone base will experience declining natural testosterone, resulting in low-T symptoms within weeks. PCT is required after any male Anavar cycle. Counterfeiting risk is higher with Anavar than almost any other anabolic steroid due to the high cost of legitimate Oxandrolone. Much of the black market supply is underdosed or contains a cheaper steroid (Dianabol being a common substitute) rather than genuine Oxandrolone.

Men — performance dose: 40–80 mg/day, split into two doses due to the ~9-hour half-life (e.g., 20–40 mg morning, 20–40 mg evening). Cycle length: 6–8 weeks maximum for oral liver safety reasons. Women — standard dose: 5–15 mg/day, with 10 mg being the typical starting point. Cycle length: 4–6 weeks. Women should monitor closely for early virilization signs and discontinue immediately if they appear. Stack note: Men almost always run Anavar alongside a testosterone base to prevent low-testosterone symptoms from suppression. A common protocol is Testosterone Enanthate 200–300 mg/week + Anavar 50–60 mg/day for 6–8 weeks, typically at the end of a bulking phase or throughout a cutting cycle. Liver support: TUDCA 250–500 mg/day and NAC 600 mg/day throughout the Anavar portion of any cycle are standard protective measures.

United States: Oxandrolone is a Schedule III controlled substance under the Anabolic Steroids Control Act. It retains FDA approval for specific medical indications (muscle wasting, weight maintenance, osteoporosis) and can be legally prescribed. Black market possession without a prescription is a federal crime. Medical access: Physician-prescribed Oxandrolone is available through regular pharmacies, though cost is significant (brand-name Oxandrin can exceed $600/month). Compounding pharmacies can produce it at lower cost with a prescription. WADA / Sports: Prohibited in all sports. Anavar has a detection window of several weeks in urine testing, shorter for some metabolites.

Anavar + Testosterone: The standard male protocol. Testosterone maintains androgenic baseline and prevents suppression symptoms; Anavar adds strength and lean mass without estrogen activity. This is the recommended approach for any male Anavar cycle. Anavar + Winstrol: A popular cutting stack adding two non-aromatizing compounds. Both suppress HDL significantly, so this combination carries elevated cardiovascular risk and requires careful lipid monitoring. Anavar + Ipamorelin/MK-677: For the aesthetics-focused user, adding a GH secretagogue to an Anavar cycle adds IGF-1 elevation and recovery support while Anavar handles the strength and lean mass retention.

Anavar — Common Questions